Basic Information
| RNALocate ID: | RLID:11003903 |
| RNA Symbol: | hsa-miR-330-5p |
| Localization: | Exosome |
RNA Information
| RNA Name: | hsa-miR-330-5p |
| RNA ID: | miRBase:MIMAT0004693 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 30542726 |
| Tissue/Cell Line: | HCC tissues |
| Method: | RNA sequencing |
|
Differentially expressed exosomal miRs between the fast- and slow-migrated groups. Originally published in Oncol Rep. Yu LX, et al, 2019. Reproduced under the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) |
|
| Description: | Six exosomal miRNAs were differentially expressed between the fast- and slow-migrated groups. In the fast-migrated group, five miRNAs (miR-140-3p, miR-30d-5p, miR-29b-3p, miR-130b-3p and miR-330-5p) were downregulated, and one miRNA (miR-296-3p) was upregulated (Fig. 4B). |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:11003904 | Exosome | Plasma | 23663360 |
| RLID-D:11000665 | Microvesicle | Blood|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells | |
| RLID-D:11001536 | Exosome | Breast milk|Cell lines|Epididymal epithelial cells|Osteoblast|Plasma|Primary glioblastoma neurosphere cells|Primary keratinocyte|Saliva|Serum|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-330-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-40598 |
| MNDR | hsa-miR-330-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-40599 |
| MNDR | hsa-miR-330-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-40600 |
| MNDR | hsa-miR-330-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-40601 |
| MNDR | hsa-miR-330-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-40602 |
| MNDR | hsa-miR-330-5p | Her2-receptor positive breast cancer | MNDR-E-MI-40603 |
| MNDR | hsa-miR-330-5p | Prostate cancer | MNDR-E-MI-40604 |
| MNDR | hsa-miR-330-5p | Gastric cancer | MNDR-E-MI-40605 |
| MNDR | hsa-miR-330-5p | Alzheimer disease | MNDR-E-MI-40606 |
| MNDR | hsa-miR-330-5p | Huntington disease | MNDR-E-MI-40607 |
| MNDR | hsa-miR-330-5p | Lung cancer | MNDR-E-MI-40608 |
| MNDR | hsa-miR-330-5p | Parkinson disease | MNDR-E-MI-40609 |
| MNDR | hsa-miR-330-5p | Breast cancer | MNDR-E-MI-40610 |
| MNDR | hsa-miR-330-5p | Pancreatic cancer | MNDR-E-MI-40611 |
| MNDR | hsa-miR-330-5p | Colon cancer | MNDR-E-MI-40612 |
| MNDR | hsa-miR-330-5p | Colon adenocarcinoma | MNDR-E-MI-40613 |
| MNDR | hsa-miR-330-5p | Relapsing-remitting multiple sclerosis | MNDR-E-MI-40614 |
| MNDR | hsa-miR-330-5p | Familial ovarian cancer | MNDR-E-MI-40615 |
| MNDR | hsa-miR-330-5p | Prostate adenocarcinoma | MNDR-E-MI-40616 |
| MNDR | hsa-miR-330-5p | Carcinoma ductal breast | MNDR-E-MI-40617 |
| MNDR | hsa-miR-330-5p | Glioblastoma | MNDR-E-MI-40618 |
| MNDR | hsa-miR-330-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-40619 |
| MNDR | hsa-miR-330-5p | Osteosarcoma | MNDR-E-MI-40620 |
| MNDR | hsa-miR-330-5p | Middle cerebral artery infarction | MNDR-E-MI-40621 |
| MNDR | hsa-miR-330-5p | Lung squamous cell carcinoma | MNDR-E-MI-40622 |
| MNDR | hsa-miR-330-5p | Non-small cell lung cancer | MNDR-E-MI-40623 |
| MNDR | hsa-miR-330-5p | Lung adenocarcinoma | MNDR-E-MI-40624 |
| MNDR | hsa-miR-330-5p | Bladder urothelial carcinoma | MNDR-E-MI-40625 |
| MNDR | hsa-miR-330-5p | Pancreatic adenocarcinoma | MNDR-E-MI-40626 |
| MNDR | hsa-miR-330-5p | Carcinoma renal cell | MNDR-E-MI-40627 |
| MNDR | hsa-miR-330-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-40628 |
| MNDR | hsa-miR-330-5p | Renal clear cell carcinoma | MNDR-E-MI-40629 |
| MNDR | hsa-miR-330-5p | Esophagus adenocarcinoma | MNDR-E-MI-40630 |
| MNDR | hsa-miR-330-5p | Cholangiocarcinoma | MNDR-E-MI-40631 |
| MNDR | hsa-miR-330-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-40632 |
| MNDR | hsa-miR-330-5p | Breast invasive carcinoma | MNDR-E-MI-40633 |
| MNDR | hsa-miR-330-5p | Hepatocellular carcinoma | MNDR-E-MI-40634 |
| MNDR | hsa-miR-330-5p | Familiar ovarian carcinoma | MNDR-E-MI-40635 |
| MNDR | hsa-miR-330-5p | Barrett's adenocarcinoma | MNDR-E-MI-40636 |
| MNDR | hsa-miR-330-5p | Neuromyelitis optica | MNDR-E-MI-40637 |
| MNDR | hsa-miR-330-5p | Skin cutaneous melanoma | MNDR-E-MI-40638 |
| MNDR | hsa-miR-330-5p | Skin melanoma | MNDR-E-MI-40639 |
| MNDR | hsa-miR-330-5p | Colorectal cancer | MNDR-E-MI-40640 |
| MNDR | hsa-miR-330-5p | Nasopharynx carcinoma | MNDR-E-MI-40641 |
| MNDR | hsa-miR-330-5p | Nasopharyngeal cancer | MNDR-E-MI-40642 |
| MNDR | hsa-miR-330-5p | Barrett's carcinogenesis | MNDR-E-MI-40643 |
| MNDR | hsa-miR-330-5p | Breast cancer her3+ negative | MNDR-E-MI-40644 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | CCND1 | Homo sapiens | RR00294821 |
TOP